Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
3 "Min Kyoung Lee"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Review Article
Thyroid
2025 Korean Thyroid Association Clinical Management Guideline on Active Surveillance for Low-Risk Papillary Thyroid Carcinoma
Eun Kyung Lee, Min Joo Kim, Seung Heon Kang, Bon Seok Koo, Kyungsik Kim, Mijin Kim, Bo Hyun Kim, Ji-hoon Kim, Shinje Moon, Kyorim Back, Young Shin Song, Jong-hyuk Ahn, Hwa Young Ahn, Ho-Ryun Won, Won Sang Yoo, Min Kyoung Lee, Jeongmin Lee, Ji Ye Lee, Kyong Yeun Jung, Chan Kwon Jung, Yoon Young Cho, Dong-Jun Lim, Sun Wook Kim, Young Joo Park, Dong Gyu Na, Jee Soo Kim
Endocrinol Metab. 2025;40(3):307-341.   Published online June 24, 2025
DOI: https://doi.org/10.3803/EnM.2025.2461
  • 9,854 View
  • 443 Download
  • 2 Web of Science
  • 5 Crossref
AbstractAbstract PDFPubReader   ePub   
The increasing detection of papillary thyroid microcarcinoma (PTMC) has raised concerns regarding overtreatment. For low-risk PTMC, either immediate surgery or active surveillance (AS) can be considered. To facilitate the implementation of AS, the Korean Thyroid Association convened a multidisciplinary panel and developed the first Korean guideline. AS is recommended for adults with pathologically confirmed Bethesda V–VI PTMC who have no clinical evidence of lymph node or distant metastasis, gross extrathyroidal extension, invasion of the trachea or recurrent laryngeal nerve, or aggressive histology. A baseline assessment requires high-resolution neck ultrasound performed by experienced operators to exclude extrathyroidal extension, tracheal or recurrent laryngeal nerve invasion, and lymph node metastasis; contrast-enhanced neck computed tomography is optional. Patient characteristics, including age, comorbidities, and the capacity for long-term follow-up, should be thoroughly assessed. Shared decision-making should carefully weigh the benefits and risks of surgery versus AS, considering expected oncologic outcomes, potential complications, quality of life, anxiety, medical costs, and patient preference. Follow-up involves neck ultrasound and thyroid function tests every 6 months for 2 years and annually thereafter. Disease progression, defined as significant tumor growth or newly detected nodal or distant metastasis, warrants surgery. Despite remaining uncertainties, this guideline provides a structured framework to ensure oncologic safety and supports patient-centered AS.

Citations

Citations to this article as recorded by  
  • Feasibility and Safety of Active Surveillance in Subcapsular Thyroid Nodules with High Suspicion for Malignancy
    Yan Hu, Wei Zhou, Lu Zhang, Weiwei Zhan
    Ultrasound in Medicine & Biology.2026; 52(4): 816.     CrossRef
  • Combined Ultrasound and MRI Assessment in Patients Undergoing Reoperation for Recurrent Papillary Thyroid Carcinoma: Oncological Outcomes and Surgical Safety
    Zimei Tang, Jie Liu, Rong Wang, Gang Tian, Anwen Ren, Jiexiao Li, Yiran Wang, Wen Yang, Peng Sun, Tao Huang, Ximeng Zhang, Jie Ming
    Current Oncology.2026; 33(2): 98.     CrossRef
  • Multidisciplinary team diagnosis and treatment of well-differentiated thyroid carcinoma: current landscape and future prospects
    Yuanyuan Li, Peijie Wang, Jiaxin Cao, Haiyan Liu
    The Oncologist.2026;[Epub]     CrossRef
  • Optimal cutoff value of fine-needle aspiration thyroglobulin of metastatic lymph node in thyroid cancer patients
    Yang Yang, Xianfeng Jiang
    European Journal of Surgical Oncology.2025; 51(11): 110428.     CrossRef
  • Low-risk thyroid cancer: surgery or active surveillance—an application of shared decision-making: a narrative review
    Min Joo Kim, Eun Kyung Lee, Sun Wook Cho, Yoo Hyung Kim, Kyu Eun Lee, Su-jin Kim, Woochul Kim, Eun-Jae Chung, Jungirl Seok, Yul Hwangbo, Young Ki Lee, Jinsun Jang, Junsun Ryu, Yuh-Seog Jung, Chang Hwan Ryu, Jae Hoon Moon, June Young Choi, Hyeong Won Yu, K
    Journal of the Korean Medical Association.2025; 68(9): 573.     CrossRef
Close layer
Original Articles
Thyroid
Thyroid Cancer Screening
Diagnostic Performance of Ultrasound-Based Risk Stratification Systems for Thyroid Nodules: A Systematic Review and Meta-Analysis
Leehi Joo, Min Kyoung Lee, Ji Ye Lee, Eun Ju Ha, Dong Gyu Na
Endocrinol Metab. 2023;38(1):117-128.   Published online February 27, 2023
DOI: https://doi.org/10.3803/EnM.2023.1670
  • 10,034 View
  • 275 Download
  • 14 Web of Science
  • 16 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
This study investigated the diagnostic performance of biopsy criteria in four society ultrasonography risk stratification systems (RSSs) for thyroid nodules, including the 2021 Korean (K)-Thyroid Imaging Reporting and Data System (TIRADS).
Methods
The Ovid-MEDLINE, Embase, Cochrane, and KoreaMed databases were searched and a manual search was conducted to identify original articles investigating the diagnostic performance of biopsy criteria for thyroid nodules (≥1 cm) in four widely used society RSSs.
Results
Eleven articles were included. The pooled sensitivity and specificity were 82% (95% confidence interval [CI], 74% to 87%) and 60% (95% CI, 52% to 67%) for the American College of Radiology (ACR)-TIRADS, 89% (95% CI, 85% to 93%) and 34% (95% CI, 26% to 42%) for the American Thyroid Association (ATA) system, 88% (95% CI, 81% to 92%) and 42% (95% CI, 22% to 67%) for the European (EU)-TIRADS, and 96% (95% CI, 94% to 97%) and 21% (95% CI, 17% to 25%) for the 2016 K-TIRADS. The sensitivity and specificity were 76% (95% CI, 74% to 79%) and 50% (95% CI, 49% to 52%) for the 2021 K-TIRADS1.5 (1.5-cm size cut-off for intermediate-suspicion nodules). The pooled unnecessary biopsy rates of the ACR-TIRADS, ATA system, EU-TIRADS, and 2016 K-TIRADS were 41% (95% CI, 32% to 49%), 65% (95% CI, 56% to 74%), 68% (95% CI, 60% to 75%), and 79% (95% CI, 74% to 83%), respectively. The unnecessary biopsy rate was 50% (95% CI, 47% to 53%) for the 2021 K-TIRADS1.5.
Conclusion
The unnecessary biopsy rate of the 2021 K-TIRADS1.5 was substantially lower than that of the 2016 K-TIRADS and comparable to that of the ACR-TIRADS. The 2021 K-TIRADS may help reduce potential harm due to unnecessary biopsies.

Citations

Citations to this article as recorded by  
  • Enhancing diagnostic accuracy of thyroid nodules: integrating self-learning and artificial intelligence in clinical training
    Daham Kim, Yoon-a Hwang, Youngsook Kim, Hye Sun Lee, Eunjung Lee, Hyunju Lee, Jung Hyun Yoon, Vivian Youngjean Park, Miribi Rho, Jiyoung Yoon, Si Eun Lee, Jin Young Kwak
    Endocrine.2025; 88(3): 766.     CrossRef
  • Interobserver agreement between artificial intelligence models in the thyroid imaging and reporting data system (TIRADS) assessment of thyroid nodules
    Andrea Leoncini, Pierpaolo Trimboli
    Endocrine.2025; 89(1): 197.     CrossRef
  • A comparative study of Chinese and ACR-TIRADS diagnostic accuracy in small thyroid nodule risk evaluation
    Rasha Nadeem Ahmed, Maysaloon Shaman Saeed, Nazar M. T. Jawhar, Mohamed Tarek El-Diasty, Noha Yahia Ebaid, Mostafa Mohamad Assy
    Egyptian Journal of Radiology and Nuclear Medicine.2025;[Epub]     CrossRef
  • Risk Stratification of Thyroid Nodules 10 mm in Diameter or Less: Strength and Pitfalls of the Ultrasonographic Assessment From a Cross‐Sectional Study
    Giuseppe Lisco, Anna De Tullio, Vito Angelo Giagulli, Giuseppina Renzulli, Vincenzo Triggiani, Suraiya Saleem
    International Journal of Endocrinology.2025;[Epub]     CrossRef
  • Ultrasound Risk Stratification of Autonomously Functioning Thyroid Nodules: Cine Loop Video Sequences Versus Static Image Captures
    Larissa Rosenbaum, Martin Freesmeyer, Tabea Nikola Schmidt, Christian Kühnel, Falk Gühne, Philipp Seifert
    Diagnostics.2025; 15(19): 2525.     CrossRef
  • Interobserver Agreement Among Thyroid Ultrasound Operators in Defining Thyroid Nodules as Subcapsular
    Pierpaolo Trimboli, Enrico Papini, Jörg Bojunga, Chiara Camponovo, Maurilio Deandrea, Antonio Giangregorio, Lauro Gianola, Giorgio Grani, Rinaldo Guglielmi, Andrea Frasoldati, Fabian Pitoia, Gilles Russ, Cosimo Durante, Andrea Leoncini
    Thyroid®.2025; 35(10): 1198.     CrossRef
  • Accuracy of ultrasound in predicting thyroid malignancy: a comparative analysis of the ACR TI-RADS and ATA risk stratification systems
    Shaza Samargandy, Aliaa H. Ghoneim
    Archives of Endocrinology and Metabolism.2024;[Epub]     CrossRef
  • Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules 2024
    Young Joo Park, Eun Kyung Lee, Young Shin Song, Su Hwan Kang, Bon Seok Koo, Sun Wook Kim, Dong Gyu Na, Seung-Kuk Baek, So Won Oh, Min Kyoung Lee, Sang-Woo Lee, Young Ah Lee, Yong Sang Lee, Ji Ye Lee, Dong-Jun Lim, Leehi Joo, Yuh-Seog Jung, Chan Kwon Jung,
    International Journal of Thyroidology.2024; 17(1): 208.     CrossRef
  • Individual Ultrasonographic Characteristics of Thyroid Nodules and Their Cytopathological Correlation to Determine Malignancy Risk
    Miguel Ángel Castilla Villanueva, Dania Guadalupe Solis Cano, Ana Amador Martínez, Marco Antonio Téliz Meneses, Jesús Baquera-Heredia, Cesar Eduardo Vallin Orozco, Mónica Loya Ceballos
    Cureus.2024;[Epub]     CrossRef
  • Improving the diagnostic performance of inexperienced readers for thyroid nodules through digital self-learning and artificial intelligence assistance
    Si Eun Lee, Hye Jung Kim, Hae Kyoung Jung, Jin Hyang Jung, Jae-Han Jeon, Jin Hee Lee, Hanpyo Hong, Eun Jung Lee, Daham Kim, Jin Young Kwak
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Systemic therapy for differentiated thyroid cancer with distant metastasis
    Eun Kyung Lee
    Journal of the Korean Medical Association.2024; 67(7): 484.     CrossRef
  • To Screen or Not to Screen?
    Do Joon Park
    Endocrinology and Metabolism.2023; 38(1): 69.     CrossRef
  • The 2017 United States Preventive Services Task Force Recommendation for Thyroid Cancer Screening Is No Longer the Gold Standard
    Ka Hee Yi
    Endocrinology and Metabolism.2023; 38(1): 72.     CrossRef
  • Thyroid Cancer Screening: How to Maximize Its Benefits and Minimize Its Harms
    Jung Hwan Baek
    Endocrinology and Metabolism.2023; 38(1): 75.     CrossRef
  • 2023 Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules
    Young Joo Park, Eun Kyung Lee, Young Shin Song, Soo Hwan Kang, Bon Seok Koo, Sun Wook Kim, Dong Gyu Na, Seung-Kuk Baek, So Won Oh, Min Kyoung Lee, Sang-Woo Lee, Young Ah Lee, Yong Sang Lee, Ji Ye Lee, Dong-Jun Lim, Leehi Joo, Yuh-Seog Jung, Chan Kwon Jung
    International Journal of Thyroidology.2023; 16(1): 1.     CrossRef
  • Evaluation of the Appropriateness of Thyroid Fine-Needle Aspiration
    Lairce Cristina Ribeiro Brito, Iara Beatriz De Carvalho Botêlho, Lanna Matos Silva Fernandes, Nayze Lucena Sangreman Aldeman, Uziel Nunes Silva
    International Journal for Innovation Education and Research.2023; 11(6): 8.     CrossRef
Close layer
Clinical Study
Effectiveness of Injecting Cold 5% Dextrose into Patients with Nerve Damage Symptoms during Thyroid Radiofrequency Ablation
Min Kyoung Lee, Jung Hwan Baek, Sae Rom Chung, Young Jun Choi, Yu-Mi Lee, Tae Yong Kim, Jeong Hyun Lee
Endocrinol Metab. 2020;35(2):407-415.   Published online June 24, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.2.407
  • 9,776 View
  • 166 Download
  • 24 Web of Science
  • 26 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
Although radiofrequency ablation (RFA) is a safe treatment for thyroid tumors, nerve damage is a frequent complication. A previous retrospective study suggested that an injection of cold 5% dextrose in water (5% DW) can reduce nerve damage during RFA. This study validated the efficacy of injecting cold 5% DW for management of nerve damage during RFA.
Methods
Between November 2017 and December 2018, 242 patients underwent 291 RFA sessions for treatment of benign thyroid nodules or recurrent thyroid cancers. Using a standardized technique, cold (0°C to 4°C) 5% DW was immediately injected around the damaged nerve into patients with any symptoms suggesting nerve damage. The incidence of nerve damage, the volume of 5% DW injected, symptom recovery time and the incidence of permanent nerve damage were evaluated.
Results
Nineteen patients experienced nerve damage symptoms related to 21 RFA sessions, including 17 patients during 19 sessions and two patients on the day after two sessions. Patients with nerve damage symptoms detected during RFA were treated by injection of a mean 41 mL (range, 3 to 260) cold 5% DW, but the two patients who experienced symptoms the next day did not receive cold 5% DW injections. Immediate recovery was observed after 15 RFA sessions in 14 patients. No patient experienced permanent nerve damage.
Conclusion
Injection of cold 5% DW is effective in managing nerve damage during RFA of thyroid lesions.

Citations

Citations to this article as recorded by  
  • Vocal Fold Immobility After Radiofrequency Ablation of Thyroid Nodules: A Survey of Laryngologists and an Algorithm for Periprocedural Voice Assessment
    Vaninder Kaur Dhillon, Catherine Fiona Sinclair
    Head & Neck.2026; 48(3): 821.     CrossRef
  • International expert consensus on thermal ablation for benign thyroid nodules (2025 Edition)
    Shi-Liang Cao, Shu-Rong Wang, Ji-Hoon Kim, Gregory W. Randolph, Song-Yuan Yu, Giovanni Mauri, Wei-Che Lin, Gang Dong, Kai-Lun Cheng, Bülent Çekiç, Song-Song Wu, Ingo Janssen, Hossam A. Ghazi, Jian-Qin Guo, Gerardo Amabile, Carlos N. Lehn, Jun-Feng He, Raf
    International Journal of Surgery.2026;[Epub]     CrossRef
  • Direct Ice Packing for Voice Changes During Thyroid Radiofrequency Ablation: A Retrospective Case Series
    Mei-Chen Yeh, Wei-Shin Yu, Hsiang-Lin Lee, Yu-Shen Lee, Kai-Lun Cheng, Osamu Isozaki
    Case Reports in Endocrinology.2026;[Epub]     CrossRef
  • Radiofrequency Ablation for Primary Thyroid Cancer
    Iram Hussain
    Endocrine Practice.2026;[Epub]     CrossRef
  • Thyroid Radiofrequency Ablation‐Thermal Effects on Recurrent Laryngeal Nerve Using Continuous Intraoperative Neuromonitoring Animal Model
    Tzu‐Yen Huang, Shih‐Wei Wang, Hsin‐Yi Tseng, Gregory W. Randolph, Gianlorenzo Dionigi, Yi‐Chu Lin, Cheng‐Hsun Chuang, I‐Cheng Lu, Chih‐Hung Lin, Leong‐Perng Chan, Feng‐Yu Chiang, Che‐Wei Wu
    Otolaryngology–Head and Neck Surgery.2025; 172(1): 63.     CrossRef
  • Radiofrequency Ablation for Recurrent Thyroid Cancers: 2025 Korean Society of Thyroid Radiology Guideline
    Eun Ju Ha, Min Kyoung Lee, Jung Hwan Baek, Hyun Kyung Lim, Hye Shin Ahn, Seon Mi Baek, Yoon Jung Choi, Sae Rom Chung, Ji-hoon Kim, Jae Ho Shin, Ji Ye Lee, Min Ji Hong, Hyun Jin Kim, Leehi Joo, Soo Yeon Hahn, So Lyung Jung, Chang Yoon Lee, Jeong Hyun Lee,
    Korean Journal of Radiology.2025; 26(1): 10.     CrossRef
  • Complications in chemical and thermal ablation of parathyroid lesions: a systematic review and meta-analysis
    So Yeong Jeong, Se Jin Cho, Jung Hwan Baek
    European Radiology.2025; 35(12): 7738.     CrossRef
  • Long-Term Outcomes of Radiofrequency Ablation in Patients with Low-Risk Papillary Thyroid Microcarcinoma
    Hunjong Lim, Min Joo Kim
    Endocrinology and Metabolism.2025; 40(3): 385.     CrossRef
  • Which Intraoperative Monitoring Method More Accurately Predicts Voice Change After Thyroid Nodule Ablation: Transcutaneous Laryngeal Ultrasonography Versus Subjective Voice Assessment
    Xiaomin Guo, Bowen Zheng, Jinfen Wang, Tao Wu, Tinghui Yin, Yufan Lian, Lei Tan, Yanping Ma, Rui Guo, Yuting He, Jie Ren
    Ultrasound in Medicine & Biology.2025; 51(10): 1846.     CrossRef
  • Scholarly Dialogue on Risk to the Recurrent Laryngeal Nerve with Thermal Ablation Procedures: A Reflection on Empirical Practices
    Marika Russell, Che-Wei Wu, Tzu-Yen Huang, R. Michael Tuttle, Peter A. Kopp, Jung Hwan Baek, Lisa A. Orloff, Julia Noel, Joseph Scharpf, Peter Angelos, Kyung Tae, Jeong Seon Park, Elizabeth Cottrill, Victoria Banuchi, MaryBeth Cunnane, Maurilio Deandrea,
    Thyroid®.2025; 35(11): 1221.     CrossRef
  • The Role of Radiofrequency Ablation in Benign and Malignant Thyroid Nodules
    Meghal Shah, Catherine McManus
    Surgical Clinics of North America.2024; 104(4): 779.     CrossRef
  • Recurrent laryngeal nerve monitoring by flexible laryngoscopy during thyroid radiofrequency ablation in the awake patient
    Marsida Teliti, Antonio Occhini, Rodolfo Fonte, Laura Croce, Benedetto Calì, Federica Antonella Ripepi, Andrea Carbone, Mario Rotondi, Spyridon Chytiris
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Long-term clinical outcomes of thermal ablation for benign thyroid nodules and unresolved issues: a comprehensive systematic review
    So Yeong Jeong, Jung Hwan Baek
    La radiologia medica.2024; 130(1): 111.     CrossRef
  • Clinical and Economic Evaluation of Ultrasound-Guided Radiofrequency Ablation vs. Parathyroidectomy for Patients with Primary Hyperparathyroidism: A Cohort Study
    Hui-hui Chai, Zhan-jing Dai, Bai Xu, Qiao-hong Hu, Hong-feng He, Ying Xin, Wen-wen Yue, Cheng-zhong Peng
    Academic Radiology.2023; 30(11): 2647.     CrossRef
  • Efficacy of single-session radiofrequency ablation (RFA) in rendering euthyroidism for persistent/relapsed Graves’ disease, a pilot study
    Man Him Matrix Fung, Brian Hung Hin Lang
    European Radiology.2023; 33(9): 6534.     CrossRef
  • Radiofrequency Ablation of Cervical Thyroid Cancer Metastases—Experience of Endocrinology Practices in the United States
    Shahzad Ahmad, Jules Aljammal, Ian Orozco, Sheharyar Raashid, Fizza Zulfiqar, Sean P Nikravan, Iram Hussain
    Journal of the Endocrine Society.2023;[Epub]     CrossRef
  • Radiofrequency ablation of benign thyroid nodules: the value of anterolateral hydrodissection
    So Yeong Jeong, Jung Hwan Baek, Sae Rom Chung, Young Jun Choi, Ki-Wook Chung, Tae Yong Kim, Jeong Hyun Lee
    Ultrasonography.2023; 42(3): 432.     CrossRef
  • Effective and Safe Application of Radiofrequency Ablation for Benign Thyroid Nodules
    Jin Yong Sung
    Journal of the Korean Society of Radiology.2023; 84(5): 985.     CrossRef
  • Assessment of thyroid-specific quality of life in patients with benign symptomatic thyroid nodules treated with radiofrequency or ethanol ablation: a prospective multicenter study
    So Yeong Jeong, Eun Ju Ha, Jung Hwan Baek, Tae Yong Kim, Yu-Mi Lee, Jeong Hyun Lee, Jeonghun Lee
    Ultrasonography.2022; 41(1): 204.     CrossRef
  • Management of Recurrent Laryngeal Nerve Injury During Radiofrequency Ablation of Thyroid Nodules
    Jules Aljammal, Iram Hussain, Shahzad Ahmad
    AACE Clinical Case Reports.2022; 8(2): 102.     CrossRef
  • Thermal Ablation for the Management of Papillary Thyroid Microcarcinoma in the Era of Active Surveillance and Hemithyroidectomy
    Sae Rom Chung, Jung Hwan Baek, Young Jun Choi, Jeong Hyun Lee
    Current Oncology Reports.2022; 24(8): 1045.     CrossRef
  • Improving Voice Outcomes after Thyroid Surgery and Ultrasound-Guided Ablation Procedures
    Pia Pace-Asciak, Jon O. Russell, Ralph P. Tufano
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Using Intra‐Operative Laryngeal Ultrasonography as a Real‐Time Tool in Assessing Vocal Cord Function During Radiofrequency Ablation of the Thyroid Gland
    Matrix Man Him Fung, Brian Hung Hin Lang
    World Journal of Surgery.2022; 46(9): 2206.     CrossRef
  • Long-term outcome of microwave ablation for benign thyroid nodules: Over 48-month follow-up study
    Jia-Rui Du, Wen-Hui Li, Cheng-Hai Quan, Hui Wang, Deng-Ke Teng
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Continuous neuromonitoring during radiofrequency ablation of benign thyroid nodules provides objective evidence of laryngeal nerve safety
    Catherine F. Sinclair, Maria J. Téllez, Roberto Peláez-Cruz, Alba Díaz-Baamonde, Sedat Ulkatan
    The American Journal of Surgery.2021; 222(2): 354.     CrossRef
  • Future Considerations and Directions for Thermal Ablative Technologies
    Jonathon Russell, Catherine F. Sinclair
    Current Otorhinolaryngology Reports.2021; 9(2): 210.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP